Fang-Tsyr Lin

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsBiomedical imagingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 25, 2023
A small-molecule inhibitor of TopBP1 exerts anti-MYC activity and synergy with PARP inhibitors.

Fang-Tsyr Lin, Kang Liu, Lidija A Wilhelms Garan

|Sep 27, 2023
DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors.

Helena Folly-Kossi, Joshua D Graves, Lidija A Wilhelms Garan

|Dec 05, 2022
Super-enhanced MARCO variant drives triple-negative breast cancer progression.

Weei-Chin Lin, Fang-Tsyr Lin

|Jan 07, 2021
ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.

Yang Xiao, Fang-Tsyr Lin, Weei-Chin Lin

|Jun 17, 2020
E2F1 sumoylation as a protective cellular mechanism in oxidative stress response.

Joshua D Graves, Yu-Ju Lee, Kang Liu

Pageof 1